An immunoenzymatic assay conducted by Chinese and American cohorts evaluated the use of cytokines and chemokines as biomarkers for RA-ILD, with a focus on MMP-7 and IP-10/CXCL10 [16]. This evidence concerns the gene MMP7 and interstitial lung disease.